17658 Federal Register / Vol. 76, No. 61 / Wednesday, March 30, 2011 / Notices 

III. What are the topics we intend to 

address at the public workshop? 

We intend to discuss a large number 

of issues at the workshop, including, but 

not limited to the following: 

• Establishment of the MDEpiNet 

infrastructure, 

• Gaps and challenges in medical 

device outcomes and epidemiologic 

studies, 

• Opportunities for medical device 

epidemiologic research and 

partnerships between the Center for 

Devices and Radiological Health and 

academia. 

IV. Where can I find out more about 

this public workshop? 

Background information on the public 

workshop, registration information, the 

agenda, information about lodging, and 

other relevant information will be 

posted, as it becomes available, on the 

Internet at http://fda-ws.s-3.net/ 

EpiNetWSApr11/. 

Dated: March 25, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–7434 Filed 3–29–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Forum for State and Territorial 

Chief Executives (National Forum) 

Program Cooperative Agreement 

AGENCY: Health Resources and Services 

Administration (HRSA), HHS. 

ACTION: Notice of Non-competitive OneYear Extension With Funds for the 

National Forum for State and Territorial 

Chief Executives (National Forum) 

Program Cooperative Agreement. 

SUMMARY: HRSA will be providing a 

one-year extension with funds in the 

amount authorized in fiscal year (FY) 

2010 to support activities that focus on 

cross-cutting publicly-funded health 

program integration and health access 

issues identified by the State and 

Territory governors and their senior 

health policy advisors, including 

addressing the needs of uninsured, 

underinsured and special needs 

populations, oral health, border health 

and health information technology as 

well as HRSA’s overall strategic goals. 

SUPPLEMENTARY INFORMATION: 

Cooperative Agreement Recipient of 

Record: National Governors Association 

Center for Best Practices (NGA), 

Washington, DC. 

Original Period of Support: April 1, 

2008, to March 31, 2011. 

Amount of Supplement Award: 

$160,000. 

Authority: Sections 241 and 301 of the 

Public Health Service Act, as amended 

(42 U.S.C. 238J and 241 respectively). 

CFDA Number: 93.224. 

Justification for the Exception to 

Competition: The National Forum 

cooperative agreement provides a 

unique vehicle for HRSA to collaborate 

with the Nation’s governors on their 

shared priorities, and provides 

opportunities through which governors 

can build on lessons others states have 

learned in addressing similar health 

policy challenges. A 1-year extension 

with funds will allow the National 

Forum to facilitate ongoing 

communication on emerging strategies 

addressing common priorities, public 

health policy, and governance issues 

affecting States and Territories thereby 

allowing HRSA to reevaluate the focus 

and implementation of this Program 

prior to the FY 2012 competition for the 

next 3-year project period. Further 

funding beyond March 31, 2012, will be 

competitively awarded in FY 2012. 

FOR FURTHER INFORMATION CONTACT: 

Mark Pincus, Director, Office of Policy 

Analysis, HRSA, via e-mail: 

mpincus@hrsa.gov or via telephone: 

301–443–5911. 

Dated: March 23, 2011. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2011–7444 Filed 3–29–11; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK Central 

Repositories Non-Renewable Sample Access 

(X01)-Hepatitis C. 

Date: April 26, 2011. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call) 

Contact Person: Najma Begum, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 749, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–8894, 

begumn@niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: March 24, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–7500 Filed 3–29–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; ‘‘Mouse Resource’’. 

Date: April 20, 2011. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817, 

(Telephone Conference Call) 

Contact Person: Gregory P. Jarosik, PhD, 

Scientific Review Administrator, Scientific 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES